ATG7 and leukemia: After an 18-h treatment with CCCP, mitochondrial mass declined in both wild-type and Atg7−/− leukemia cells, and this degradation could be blocked by 10 nM bafilomycin A1 (Baf-A1), a lysosomal inhibitor (Fig. 3D).